Results 191 to 200 of about 57,632 (243)

Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma. [PDF]

open access: yesJ Immunother Cancer
O'Reilly EM   +22 more
europepmc   +1 more source

A Systematic Review of Literature: TNF‐α Blockers and JAK Inhibitors for the Treatment of Stevens‐Johnson Syndrome, Toxic Epidermal Necrolysis, and Severe Forms of Erythema Multiforme

open access: yesHealth Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Stevens‐Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), and erythema multiforme major (EM major) are severe dermatologic conditions characterized by varying degrees of skin detachment and involvement of mucosal membranes, often triggered by drug reactions or infections.
Sadaf Salehi   +6 more
wiley   +1 more source

Early methylprednisolone pulses and prevention of long-term damage accrual in active systemic lupus erythematosus: a propensity score analysis of the Lupus-Cruces-Bordeaux cohort. [PDF]

open access: yesRMD Open
Marín-García B   +6 more
europepmc   +1 more source

Evolution of therapy for autoimmune diseases in pregnancy: a retrospective study from 2000 to 2023. [PDF]

open access: yesFront Med (Lausanne)
Garufi C   +8 more
europepmc   +1 more source

Lupus erythematosus-specific bullous lesions: A case report. [PDF]

open access: yesMedicine (Baltimore)
Li S, Zhang M, Nie Y, Yang X.
europepmc   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Home - About - Disclaimer - Privacy